Assignee
SPERO THERAPEUTICS INC
US·7 granted patents·6 pending applications·4 citations·filing 2017–2024
Top patents by PatentIndex Score
13 records- 0183US12048691B2High dosage tebipenem pivoxil tablet formulationSPERO THERAPEUTICS INC·Filed 2021·Granted Jul 30, 2024·1 cites·25 claims
- 0283US2025051334A1Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0382US12098155B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2023·Granted Sep 24, 2024·0 cites·16 claims
- 0479US10889587B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·1 cites·16 claims
- 0574US11459357B2Polymyxin compoundsSPERO THERAPEUTICS INC·Filed 2019·Granted Oct 4, 2022·2 cites·14 claims
- 0672US11718621B2Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of useSPERO THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·0 cites·16 claims
- 0771US2023322858A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US2025049766A1High dosage tebipenem pivoxil tablet formulationSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0967US2025009718A1Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1066US12528837B2Aryl substituted polymyxin derivativesSPERO THERAPEUTICS INC·Filed 2022·Granted Jan 20, 2026·0 cites·19 claims
- 1164US2024366599A1Human efficacious dose and dosage schedule of spr720SPERO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1259US2021221848A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1357US12226403B2Tebipenem pivoxil immediate and modified release oral dosage formsSPERO THERAPEUTICS INC·Filed 2017·Granted Feb 18, 2025·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →